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cedure in anamnesis, 3 pts had initial changes on ECG. In 1 case we
had alcohol leakage from septal branch to LAD – aspiration, absence of
MACE. Also we had 1 case of ventricular ﬁbrillation on the 10-th day
after procedure. Mean interventricular wall thickness decreased from
2,5  0,3cm to 1,9  0,1cm. MR decreased from at least moderate to
mild or complete disappearance. NYHA class reduced from 2,9 to 1,1.
CONCLUSIONS ASA is effective and safe method of HOCM treatment.
The reduction of the duration of the procedure, decreasing of the number
of the complications and general improvement of the results of interven-
tional HOCM treatment are possible with accumulation of the experience.
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BACKGROUND Septal myectomy is the gold standard for medically-
refractory patients with hypertrophic obstructive cardiomyopathy
(HCM). There is a subset of patients who have severe exertional
symptoms without a resting or provocable left ventricular outﬂow
tract (LVOT) gradient on noninvasive testing. These patients may
demonstrate obstruction on hemodynamic catheterization with
isoproterenol challenge but is has remained unclear how they respond
to septal reduction therapy. We aimed to assess the ability of
isoproterenol challenge to predict symptom resolution with myec-
tomy in a selected HCM population.
METHODS 18 symptomatic HCM patients (NYHA class III or IV) with
labile obstruction on isoproterenol challenge underwent surgical
myectomy between February 2003 and April 2009. Patients were
reassessed for symptom resolution after a median of 4 (IQR 3-7) years.
RESULTS Post-myectomy, 13 patients (72.2%) had complete symptom
resolution, while 5 (27.8%) had improved but persistent symptoms. Pa-
tients with complete symptom resolution had a greater increase in left
atrial pressure (LAP) and tau with isoproterenol [3 (IQR -2-8) mmHg vs. -5
(IQR -8.5–1) mmHg; p¼0.01] and [-0.7 (IQR -13-22) ms vs. -44 (IQR -48–0.2)
ms; p¼0.03] (Figure 1). The mean change in LVOT gradient with peak
isoproterenol was signiﬁcantly greater among patients with complete
symptom resolution compared to patients with improved but persistent
symptoms [(104 (IQR 66-123) mmHg vs. 55 (IQR 38-74) mmHg; p¼0.01).
All patients with increase in LAP with isoproterenol and LVOT gradient
>100 mmHg achieved complete symptom resolution.CONCLUSIONS Patients with residual symptoms post-myectomy had
less increase in LAP and tau with isoproterenol indicating a “ﬁxed”
component to diastolic ﬁlling, as opposed to patients with symptom
resolution whose response was indicative of elevation in ﬁlling pres-
sures secondary to dynamic obstruction.
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BACKGROUND Current practice guidelines suggest that ASA may be
the treatment of choice for elderly patients with medically refractory
symptomatic HOCM because of the risks associated with cardiac sur-
gery in this patient population. We sought to determine the outcomes
and complications in elderly patients who undergo ASA.
METHODS 220 alcohol septal ablations were performed on 198 pa-
tients age 65 years or older (age 73 5y, 68% F) over a 15 year period.
Subgroup analyses were performed for patients 75 years of age
(n¼73, 80% F) and for patients age 65-74 (n¼125, 61% F).
RESULTS Of 220 ASA procedures performed, the primary endpoint of
in-hospital death occurred in four patients (1.8%). Among patients 
75 years of age (79 procedures) three patients died (4%) compared to
one death (0.7%) among patients age 65-74 years of age (141 ASA
procedures). 26 (11.8%) were repeat ablations. Complete heart block
(CHB) requiring permanent pacemaker occurred in 21 patients (9.5%).
For patients age  75 years the rate CHB requiring pacemaker im-
plantation was 11.3%. Bleeding or access site complications were re-
ported in eight patients (4.1%) among the entire cohort. Bleeding or
access site complications occurred in ﬁve patients (3.5%) who were 
75 years of age at the time of procedure.
CONCLUSIONS This study shows the safety of ASA in elderly patients.
Compared to the entire cohort of patients all ages undergoing ASA, the
elderly did not have a statistically signiﬁcant difference in complete
heart block requiring pacemaker implantation, bleeding/access site
complications, or procedural mortality. Although mortality rate of the
elderly cohort was not increased over historic controls, patients >75
years of age had statistically signiﬁcant higher mortality than patients
65-74 years of age.65-75y >75y Total P-ValueNumber of patients
(procedures)125 (141) 73 (79) 198 (220) -Deaths: number (%) 1 (0.7%) 3(4%) 4(1.8%) 0.0002CHB: number(%) 12 (5.4%) 9 (11.3%) 21 (9.5%) 0.39Bleeding/access
complication4 (5.0%) 5 (3.5%) 9(4.1%) 0.21CATEGORIES STRUCTURAL: Alcohol Septal Ablation/HOCM
KEYWORDS Ablation, alcohol septal, Hypertrophic cardiomyopathy
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BACKGROUND Alcohol septal ablation (ASA) is an established treat-
ment for symptomatic hypertrophic obstructive cardiomyopathy
(HOCM). The impact of race and gender on the results of ASA in pa-
tients with HOCM has not been reported in the literature.
METHODS Six hundred and forty-ﬁve patients with symptomatic HOCM
despite optimal medical therapy underwent ASA at a single center over a
ﬁfteen-year timeperiod (1999 to 2014). All patientswere grouped according
